Genocea Beats Investor Claims It Hid Truth About Herpes Drug
A Massachusetts federal judge dismissed a proposed investor class action Thursday against Genocea Biosciences Inc., saying accusations that the company hid negative test results before announcing it could not finance ongoing...To view the full article, register now.
Already a subscriber? Click here to view full article